Related Experiment Video
Updated: Aug 31, 2025

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Association of Systemic Vascular Resistance Analog and Cardiovascular Outcomes: The Heart and Soul Study
Dai-Yin Lu1,2, Qizhi Fang1, Dwight Bibby1
1Division of Cardiology University of California San Francisco CA.
Insights
An elevated estimated systemic vascular resistance (eSVR) is linked to increased cardiovascular events in patients with coronary artery disease. Persistently high eSVR indicates a higher risk of adverse outcomes.
Area of Science:
- Cardiology
- Hemodynamics
- Echocardiography
Background:
- Systemic vascular resistance (SVR) is a key hemodynamic parameter.
- Estimated SVR (eSVR) derived from echocardiography correlates with direct SVR measurements.
- The prognostic value of eSVR has not been established.
Purpose of the Study:
- To investigate the prognostic impact of baseline and follow-up eSVR on cardiovascular outcomes in patients with coronary artery disease.
- To determine if eSVR is a better predictor of cardiovascular events than systolic blood pressure alone.
Main Methods:
- Utilized data from 984 participants with established coronary artery disease in the Heart and Soul Study.
- Defined Doppler-derived eSVR as the ratio of systolic blood pressure to left ventricular outflow tract velocity time integral.
- Categorized participants into baseline eSVR tertiles and assessed cardiovascular outcomes, including heart failure, major cardiovascular events, and all-cause death, with follow-up eSVR calculated at year five.
Main Results:
- Higher baseline eSVR tertiles were associated with older age, higher systolic blood pressure, and lower left ventricular outflow tract velocity time integral.
- An elevated eSVR was significantly associated with increased risks of heart failure, major cardiovascular events (HR 1.38, 95% CI 1.02-1.86), and death.
- Persistently elevated eSVR during follow-up correlated with the most adverse cardiovascular outcomes.
Conclusions:
- Elevated eSVR, calculated from systolic blood pressure and left ventricular outflow tract velocity time integral, demonstrates a stronger correlation with cardiovascular events than systolic blood pressure alone.
- Repeatedly elevated eSVR is a significant predictor of adverse cardiovascular outcomes in patients with coronary artery disease.
Abstract:
Background Systemic vascular resistance (SVR) is an integral component of the hemodynamic profile. Previous studies have demonstrated a close correlation between an estimated SVR analog (eSVR) based on echocardiographic methods and SVR by direct hemodynamic measurement. However, the prognostic impact of eSVR remains unestablished. Methods and Results Study participants with established coronary artery disease from the Heart and Soul Study formed this study cohort. We defined Doppler-derived eSVR as the ratio of systolic blood pressure to left ventricular outflow tract velocity time integral. Study participants were separated based on baseline eSVR tertile: <5.6, 5.6 to <6.9, and ≧6.9. An elevated eSVR was defined as an eSVR in the third tertile (≧6.9). Follow-up eSVR was calculated at the fifth year of checkup. Cardiovascular outcomes included heart failure, major cardiovascular events, and all-cause death. Among the 984 participants (67±11 years old, 82% men), subjects with the highest baseline eSVR tertile were the oldest, with the highest systolic blood pressure and lowest left ventricular outflow tract velocity time integral. A higher eSVR was associated with increased risk of heart failure, major cardiovascular events, and death. The hazard ratio for major cardiovascular events was 1.38 (95% CI, 1.02-1.86, P=0.03) for subjects with the highest eSVR tertile compared with the lowest. In addition, those with a persistently elevated eSVR during follow-up had the most adverse outcomes. Conclusions An elevated eSVR, derived by the ratio of systolic blood pressure and left ventricular outflow tract velocity time integral, was more closely correlated with cardiovascular events than systolic blood pressure alone. Repeatedly elevated eSVR was associated with more adverse outcomes.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiovascular Drugs: Classification based on Therapeutic Indications
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

